Product Reports Resources Pricing Login Book a demo

RDS

Biotech & Life Sciences · Strasbourg, France · Founded 2020

Wearable remote monitoring for actionable clinical insights MoreLess

RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology is aimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies.

The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings.

The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians.

In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology.

Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Sustainable Healthcare Systems.

Company overview

RDS company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2020
Headquarters
Strasbourg, France
Employees
152
Open positions
1
Dealroom signal
88.4
client focusb2btechnologyArtificial IntelligencetechnologyHardwaretechnologyBig DatatechnologyDeep TechtechnologyConnected Devicesub industryBioTechnologysub industryMedical Devicessub industryHealth Platformbusiness modelManufacturingindustryHealthsectorBiotechnologysectorRemote MonitoringsectorCore AI

Valuation & funding

RDS funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Sep 2025 $15M $62M Capital Grand Est · MACSF · Critical Path Ventures · Bpifrance
SEEDEquity / VC Dec 2023 $2.2M $8.8M Capital Grand Est · MACSF
SEEDEquity / VC Aug 2023 $3.3M $13M Undisclosed
SEEDEquity / VC Jan 2021 $2.2M $8.8M Undisclosed
OtherOther financing Feb 2020 $1.1M Sam Eletr · Elie Lobel · Institute of Image-Guided Surgery · IRCAD
SPINOUTOther financing Jan 2020 Institute of Image-Guided Surgery · University of Strasbourg
Showing 6 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 153
2025 133
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

RDS website traffic

Latest recorded traffic for RDS is 1.2K monthly website visits, down 47.8% over the last three months. RDS's team grew 14.3% over the past year.

Latest monthly visits1.2K 3-month web change-47.8% 1-year team growth+14.3%
Monthly website visits91 observations · Oct 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

RDS compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

13 investors on RDS's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Capital Grand Est
MACSF
Series A 2 investors entered at this stage
Bpifrance
Critical Path Ventures
Other known 9 additional known investors
Institute of Image-Guided Surgery
Bernard Daugeras
Elie Lobel
IRCAD
Michel Ronc
Sam Eletr
University of Strasbourg
Future4Care
SEMIA

Global footprint

Where RDS has talent and traffic

Workforce by country
3 countries with
team presence
🇫🇷 France94.3%
🇮🇹 Italy2.9%
🇺🇸 United States2.9%
3 countries shown

In the news

Latest news about RDS

Recent press, funding announcements, and product moves mentioning RDS — open to read from the original sources.

See all news

Market sentiment

What the market is saying about RDS

An AI-synthesized read of the highest-engagement posts about RDS on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See RDS’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.